» Articles » PMID: 35743036

Distinct Roles of NANOS1 and NANOS3 in the Cell Cycle and NANOS3-PUM1-FOXM1 Axis to Control G2/M Phase in a Human Primordial Germ Cell Model

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jun 24
PMID 35743036
Authors
Affiliations
Soon will be listed here.
Abstract

Nanos RNA-binding proteins are critical factors of germline development throughout the animal kingdom and their dysfunction causes infertility. During evolution, mammalian Nanos paralogues adopted divergent roles in germ cell biology. However, the molecular basis behind this divergence, such as their target mRNAs, remains poorly understood. Our RNA-sequencing analysis in a human primordial germ cell model-TCam-2 cell line revealed distinct pools of genes involved in the cell cycle process downregulated upon NANOS1 and NANOS3 overexpression. We show that NANOS1 and NANOS3 proteins influence different stages of the cell cycle. Namely, NANOS1 is involved in the G1/S and NANOS3 in the G2/M phase transition. Many of their cell cycle targets are known infertility and cancer-germ cell genes. Moreover, NANOS3 in complex with RNA-binding protein PUM1 causes 3'UTR-mediated repression of mRNA encoding a transcription factor crucial for G2/M phase transition. Interestingly, while NANOS3 and PUM1 act as post-transcriptional repressors of FOXM1, FOXM1 potentially acts as a transcriptional activator of NANOS3, PUM1, and itself. Finally, by utilizing publicly available RNA-sequencing datasets, we show that the balance between FOXM1-NANOS3 and FOXM1-PUM1 expression levels is disrupted in testis cancer, suggesting a potential role in this disease.

Citing Articles

Impacts of vaping and marijuana use on airway health as determined by exhaled breath condensate (EBC).

Rojas D, McCartney M, Borras E, Hicks T, Lam T, Kenyon N Respir Res. 2025; 26(1):63.

PMID: 39984952 PMC: 11846476. DOI: 10.1186/s12931-025-03147-3.


Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment.

Wang T, Lei Y, Sun J, Wang L, Lin Y, Wu Z Front Oncol. 2025; 14:1536406.

PMID: 39927118 PMC: 11802438. DOI: 10.3389/fonc.2024.1536406.


FOXM1: a new therapeutic target of extramammary Paget disease.

Ito T, Tanaka Y, Kaku-Ito Y, Oda Y, Nakahara T Sci Rep. 2024; 14(1):4048.

PMID: 38374400 PMC: 10876583. DOI: 10.1038/s41598-024-54773-8.


Comprehensive clinicopathological significance and putative transcriptional mechanisms of Forkhead box M1 factor in hepatocellular carcinoma.

Wu H, Luo L, Wei F, Jiang H World J Surg Oncol. 2023; 21(1):366.

PMID: 38001498 PMC: 10675979. DOI: 10.1186/s12957-023-03250-z.


The RNA-binding protein NANOS1 controls hippocampal synaptogenesis.

Maschi D, Fernandez-Alvarez A, Boccaccio G PLoS One. 2023; 18(4):e0284589.

PMID: 37058523 PMC: 10104283. DOI: 10.1371/journal.pone.0284589.


References
1.
Yao L, Cong R, Ji C, Zhou X, Luan J, Meng X . RNA-Binding Proteins Play an Important Role in the Prognosis of Patients With Testicular Germ Cell Tumor. Front Genet. 2021; 12:610291. PMC: 7990889. DOI: 10.3389/fgene.2021.610291. View

2.
Haraguchi S, Tsuda M, Kitajima S, Sasaoka Y, Nomura-Kitabayashid A, Kurokawa K . nanos1: a mouse nanos gene expressed in the central nervous system is dispensable for normal development. Mech Dev. 2003; 120(6):721-31. DOI: 10.1016/s0925-4773(03)00043-1. View

3.
Bruggeman J, Koster J, Lodder P, Repping S, Hamer G . Massive expression of germ cell-specific genes is a hallmark of cancer and a potential target for novel treatment development. Oncogene. 2018; 37(42):5694-5700. PMC: 6193945. DOI: 10.1038/s41388-018-0357-2. View

4.
Bailey T . STREME: accurate and versatile sequence motif discovery. Bioinformatics. 2021; 37(18):2834-2840. PMC: 8479671. DOI: 10.1093/bioinformatics/btab203. View

5.
Wu Y, Lin J, Piluso L, Dhahbi J, Bobadilla S, Spindler S . Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response. Mol Cell. 2013; 53(1):63-74. PMC: 3919457. DOI: 10.1016/j.molcel.2013.10.031. View